LIP
CCCC icon

Lighthouse Investment Partners’s C4 Therapeutics CCCC Stock Holding History

Lighthouse Investment Partners’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,660
Closed -$64.3K – 754
2025
Q4 		$64.3K Buy
+33,660
New +$79.7K ﹤0.01% 840
2024
Q1 		– Sell
-21,981
Closed -$124K – 387
2023
Q4 		$124K Buy
+21,981
New +$50.1K 0.01% 278

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Lighthouse Investment Partners's CCCC Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of C4 Therapeutics (CCCC) in Q1 2026, closing a stake of 33,660 shares — an estimated $64.3K sold.

Lighthouse Investment Partners first reported a position in CCCC in Q4 2023 and held it in 2 quarters. The position peaked at $124K in Q4 2023. 123 funds tracked by Wall St. Rank hold CCCC as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining C4 Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 33,660 C4 Therapeutics shares in Q1 2026, an estimated $64.3K.
  • Lighthouse Investment Partners first reported a position in C4 Therapeutics in Q4 2023 and held it in 2 quarters.
  • Lighthouse Investment Partners's C4 Therapeutics position peaked at $124K in Q4 2023.
  • 123 funds tracked by Wall St. Rank held C4 Therapeutics as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.